Sfoglia per Rivista
The kinetic features of human acute leukaemia as a guide to its chemotherapeutic management.
1977-01-01 MASERA P ;MATERA L ;GAVOSTO F
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES
2009-01-01 M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML WorkingParty experience after a 7-year follow-up
2009-01-01 Palandri F; Castagnetti F; Alimena G; Testoni N; Breccia M; Luatti S; Rege-Cambrin G; Stagno F; Specchia G; Martino B; Levato L; Merante S; Liberati AM; Pane F; Saglio G; Alberti D; Martinelli G; Baccarani M; Rosti G.
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)
2012-01-01 Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party
2010-01-01 Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G.
The prognostic value of bone involvement in childhood acute lymphoblastic leukaemia (author's transl)
1981-01-01 Pastore G; Miniero R; Cordero di Montezemolo L; Felicioni V; Fiandino G; Grazia G; Morgando MP; Trada M; Madon E.
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
2010-01-01 Palandri F; Castagnetti F; Iacobucci I; Martinelli G; Amabile M; Gugliotta G; Poerio A; Testoni N; Breccia M; Bocchia M; Crugnola M; Rege-Cambrin G; Martino B; Pierri I; Radaelli F; Specchia G; Pane F; Saglio G; Rosti G; Baccarani M.
The role of BCR/ABL isoforms in the presentation and outcome of patients withPhiladelphia-positive acute lymphoblastic leukemia: a seven-year update of theGIMEMA 0496 trial.
2006-01-01 Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R; GIMEMA Leukemia Working Party
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT
2009-01-01 Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
The unbalanced ratio between KTS- and KTS+ isoforms of WT1 may probably be responsible for the dysfunction of its physiological role in leukemic cells
2005-01-01 Defilippi I; Messa F; Arruga F; Serra A; Rosso V; Catalano R; Reviglione R; Morotti A; Messa E; Carturan S; Gottardi E; Bracco E; Saglio G; Cilloni D
The use of differentiated regimens in therapy of children with acute lymphoblastic leukemia
1983-01-01 Madon E; Pastore G; Cordero Di Montezemolo L; Grazia G; Brach Del Prever A.
Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors
2001-01-01 IOLASCON A;GIORDANO P;STORELLI S;LI HH;COPPOLA B;PIGA A;FANTOLA E;FORNI G;CIANCIULLI P;PERROTTA S;MAGNANO C;MAGGIO A;MANGIAGLI A;DEVOTO M
Thrombophilic mutations are a main risk factor for placental abruption.
2003-01-01 Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C.
THROMBOPROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLEMYELOMA PATIENTS TREATED WITH LENALIDOMIDE-BASEDREGIMENS: A RANDOMIZED PHASE III STUDY OF ASPIRINVS ENOXAPARIN
2011-01-01 A Larocca; F Cavallo; A Evangelista; F Di Raimondo; L Catalano; M Galli; C Cangialosi; G Benevolo; D Rossi; T Guglielmelli; L Masini;F Rossi; R Ria; N Cascavilla; N Pescosta;A Baraldi; M Marcatti; T Caravita Di Toritto;A Nagler;M Boccadoro; A Palumbo
THYMIC OUTPUT AND T CELL RECONSTITUTION FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING
2008-01-01 Bruno B; Sfiligoi C; Omedè P; Cena S; Spagnolo M; Testa C; Cimolin L; Resta I; Sorasio R; Resta I; Giaccone L; Boccadoro M
Total body irradiation: Recent radiobiological and technological acquisitions [Irradiazione corporea totale: Recenti acquisizioni radiobiologiche e tecnologiche]
2008-01-01 Corvò; R.; Barra; S.; Filippi; A.; Ricardi; U.
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation
2010-01-01 M. Poli;S. Luscieti;V. Gandini;F. Maccarinelli;D. Finazzi;L. Silvestri;A. Roetto;P. Arosio
Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes
2005-01-01 REGE-CAMBRIN, G; Giugliano, E; Michaux, L; Stul, M; Scaravaglio, P; Serra, A; Saglio, G; Hagemeijer, A.
The tryptophan metabolism in the immune dysregulation of multiple myeloma
2007-01-01 Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M
TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS
2003-01-01 Bringhen S; Bertola A; Cavallo F; Falco P; Massaia M; Bruno B; Barbui A; Caravita T; Musto P; Pescosta N; Rossini F; Vignetti M; Boccadoro M; Palumbo A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The kinetic features of human acute leukaemia as a guide to its chemotherapeutic management. | 1977 | MASERA P ;MATERA L ;GAVOSTO F | |
| THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES | 2009 | M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia | |
| The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML WorkingParty experience after a 7-year follow-up | 2009 | Palandri F; Castagnetti F; Alimena G; Testoni N; Breccia M; Luatti S; Rege-Cambrin G; Stagno F; Specchia G; Martino B; Levato L; Merante S; Liberati AM; Pane F; Saglio G; Alberti D; Martinelli G; Baccarani M; Rosti G. | |
| The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) | 2012 | Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party | 2010 | Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G. | |
| The prognostic value of bone involvement in childhood acute lymphoblastic leukaemia (author's transl) | 1981 | Pastore G; Miniero R; Cordero di Montezemolo L; Felicioni V; Fiandino G; Grazia G; Morgando MP; Trada M; Madon E. | |
| The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase | 2010 | Palandri F; Castagnetti F; Iacobucci I; Martinelli G; Amabile M; Gugliotta G; Poerio A; Testoni N; Breccia M; Bocchia M; Crugnola M; Rege-Cambrin G; Martino B; Pierri I; Radaelli F; Specchia G; Pane F; Saglio G; Rosti G; Baccarani M. | |
| The role of BCR/ABL isoforms in the presentation and outcome of patients withPhiladelphia-positive acute lymphoblastic leukemia: a seven-year update of theGIMEMA 0496 trial. | 2006 | Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R; GIMEMA Leukemia Working Party | |
| THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT | 2009 | Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M. | |
| The unbalanced ratio between KTS- and KTS+ isoforms of WT1 may probably be responsible for the dysfunction of its physiological role in leukemic cells | 2005 | Defilippi I; Messa F; Arruga F; Serra A; Rosso V; Catalano R; Reviglione R; Morotti A; Messa E; Carturan S; Gottardi E; Bracco E; Saglio G; Cilloni D | |
| The use of differentiated regimens in therapy of children with acute lymphoblastic leukemia | 1983 | Madon E; Pastore G; Cordero Di Montezemolo L; Grazia G; Brach Del Prever A. | |
| Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors | 2001 | IOLASCON A;GIORDANO P;STORELLI S;LI HH;COPPOLA B;PIGA A;FANTOLA E;FORNI G;CIANCIULLI P;PERROTTA S;MAGNANO C;MAGGIO A;MANGIAGLI A;DEVOTO M | |
| Thrombophilic mutations are a main risk factor for placental abruption. | 2003 | Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C. | |
| THROMBOPROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLEMYELOMA PATIENTS TREATED WITH LENALIDOMIDE-BASEDREGIMENS: A RANDOMIZED PHASE III STUDY OF ASPIRINVS ENOXAPARIN | 2011 | A Larocca; F Cavallo; A Evangelista; F Di Raimondo; L Catalano; M Galli; C Cangialosi; G Benevolo; D Rossi; T Guglielmelli; L Masini;F Rossi; R Ria; N Cascavilla; N Pescosta;A Baraldi; M Marcatti; T Caravita Di Toritto;A Nagler;M Boccadoro; A Palumbo | |
| THYMIC OUTPUT AND T CELL RECONSTITUTION FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING | 2008 | Bruno B; Sfiligoi C; Omedè P; Cena S; Spagnolo M; Testa C; Cimolin L; Resta I; Sorasio R; Resta I; Giaccone L; Boccadoro M | |
| Total body irradiation: Recent radiobiological and technological acquisitions [Irradiazione corporea totale: Recenti acquisizioni radiobiologiche e tecnologiche] | 2008 | Corvò; R.; Barra; S.; Filippi; A.; Ricardi; U. | |
| Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation | 2010 | M. Poli;S. Luscieti;V. Gandini;F. Maccarinelli;D. Finazzi;L. Silvestri;A. Roetto;P. Arosio | |
| Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes | 2005 | REGE-CAMBRIN, G; Giugliano, E; Michaux, L; Stul, M; Scaravaglio, P; Serra, A; Saglio, G; Hagemeijer, A. | |
| The tryptophan metabolism in the immune dysregulation of multiple myeloma | 2007 | Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M | |
| TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS | 2003 | Bringhen S; Bertola A; Cavallo F; Falco P; Massaia M; Bruno B; Barbui A; Caravita T; Musto P; Pescosta N; Rossini F; Vignetti M; Boccadoro M; Palumbo A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile